Found: 1
Select item for more details and to access through your institution.
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 401, p. 1, doi. 10.1126/scitranslmed.aam7049
- By:
- Publication type:
- Article